Oxford Biomedica PLC ORD 1P

OXB 
(LSE, Stocks) 
 
p 15,10 <%= Resources.Global.txtUp %>
Opdateret 15:43:05
Ændring % 0,80% Stigning i aktiekurs
Ændring 0,12 Stigning i aktiekurs
Volume 10.714.002
Høj P 15,14
Lav P 14,82
Åben P 14,98
ISIN GB0006648157
Seneste luk P 14,98
# af aktier 3.284,31M
Markedsværdi 49.593M GBX
I dag

Market closed
Oxford Biomedica PLC ORD 1P
Markedet er lukket, åbner klokken 09:00
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  15,10 0,7% Stigning i aktiekurs 25,8% Stigning i aktiekurs 25,8% Stigning i aktiekurs 76,6% Stigning i aktiekurs 199,6% Stigning i aktiekurs
Powered by TradingView

Firmaprofil

Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focusses on the field of immunotherapy by managing a platform of technologies in designing gene based medicines. Its registered product LentiVector is a proprietary single dose gene therapy platform, through which it develops gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
24. maj 2018 17:45:40
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180524.2 - EUROWEB2 - 2018-05-24 17:45:40 - 2018-05-24 17:45:40 - 1 - Website: OKAY